Bain Capital Life Sciences Investors, LLC
CIK 0001703031
Director10% Owner
Filings
11
Latest May 22, 2026
Issuers covered
8
Showing
11 of 11
Page 1
Track record
10 of 10 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 10 | 30% | +0.2% | -5.5% | +59.3% | -28.9% |
| 90 days | 5 | 20% | -23.0% | -46.8% | +43.8% | -54.4% |
| 180 days | 4 | 25% | -21.8% | -14.7% | +20.5% | -78.2% |
| 365 days | 4 | 50% | +95.4% | +63.5% | +344.7% | -90.2% |
Issuers
Companies where Bain Capital Life Sciences Investors, LLC has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| HTFL | Heartflow, Inc. | 3 | Apr 30, 2026 |
| SLDB | Solid Biosciences Inc. | 2 | Feb 21, 2025 |
| ANNX | Annexon, Inc. | 1 | May 30, 2023 |
| KLRA | Kailera Therapeutics, Inc. | 1 | Apr 20, 2026 |
| KYTX | Kyverna Therapeutics, Inc. | 1 | Feb 14, 2024 |
| NAMS | Newamsterdam Pharma Co N.V. | 1 | Dec 17, 2024 |
| OLMA | Olema Pharmaceuticals, Inc. | 1 | Jan 13, 2025 |
| RPID | Rapid Micro Biosystems, Inc. | 1 | May 22, 2026 |
All filings
11 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|